Research Update: Bioplan USA Inc. Downgraded To 'B-' From 'B' On Continued Weak Post-Merger Credit Metrics; Outlook Negative - S&P Global Ratings’ Credit Research

Research Update: Bioplan USA Inc. Downgraded To 'B-' From 'B' On Continued Weak Post-Merger Credit Metrics; Outlook Negative

Research Update: Bioplan USA Inc. Downgraded To 'B-' From 'B' On Continued Weak Post-Merger Credit Metrics; Outlook Negative - S&P Global Ratings’ Credit Research
Research Update: Bioplan USA Inc. Downgraded To 'B-' From 'B' On Continued Weak Post-Merger Credit Metrics; Outlook Negative
Published Jan 15, 2016
Published Jan 15, 2016
Price US$ 225.00  |  Buy this Report Now

About This Report

  
Abstract:

U.S.-based global sampling provider Bioplan USA Inc. has underperformed our expectations since its merger in September 2014. We are lowering our corporate credit rating on Bioplan to 'B-' from 'B'. We are also lowering our issue-level ratings on the company's first-lien debt to 'B' from 'B+' and second-lien term loan to 'CCC+' from 'B-'. The recovery ratings remain unchanged. The negative rating outlook on Bioplan reflects the risk that the company may not be able to reverse its negative operating trends and its discretionary cash flow could remain negative in 2016. On Jan. 15, 2016, Standard&Poor's Ratings Services lowered its corporate credit rating on U.S.-based global sampling provider Bioplan USA Inc. to 'B-' from 'B'. The rating outlook

  
Report Type:

Research Update

Issuer
Bioplan USA Inc.
GICS
Paper Packaging (15103020)
Sector
Global Issuers
Country
United States
Region
United States
Format:
PDF Adobe Acrobat
Buy Now

More from S&P Global Ratings’ Credit Research

S&P Global Ratings’ Credit Research—S&P Global Ratings’ credit research provides analysis on issuers and debt obligations of corporations, states and municipalities, financial institutions, insurance companies and sovereign governments. S&P Global Ratings also offers insight into the credit risk of structured finance deals, providing an independent view of credit risk associated with a growing array of debt-securitized instruments.

About the Author


Cite this Report

  
MLA:
S&P Global Ratings’ Credit Research. "Research Update: Bioplan USA Inc. Downgraded To 'B-' From 'B' On Continued Weak Post-Merger Credit Metrics; Outlook Negative" Jan 15, 2016. Alacra Store. May 16, 2025. <http://www.alacrastore.com/s-and-p-credit-research/Research-Update-Bioplan-USA-Inc-Downgraded-To-B-From-B-On-Continued-Weak-Post-Merger-Credit-Metrics-Outlook-Negative-1563386>
  
APA:
S&P Global Ratings’ Credit Research. (). Research Update: Bioplan USA Inc. Downgraded To 'B-' From 'B' On Continued Weak Post-Merger Credit Metrics; Outlook Negative Jan 15, 2016. New York, NY: Alacra Store. Retrieved May 16, 2025 from <http://www.alacrastore.com/s-and-p-credit-research/Research-Update-Bioplan-USA-Inc-Downgraded-To-B-From-B-On-Continued-Weak-Post-Merger-Credit-Metrics-Outlook-Negative-1563386>
  
US$ 225.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.